These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32139504)

  • 1. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
    Terada T; Obi T; Bunai T; Matsudaira T; Yoshikawa E; Ando I; Futatsubashi M; Tsukada H; Ouchi Y
    Neurology; 2020 Apr; 94(15):e1592-e1604. PubMed ID: 32139504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in in vitro microglial accumulation of the energy metabolism tracers [
    Suzuki C; Han S; Kesavamoorthy G; Kosugi M; Araki K; Harada N; Kanazawa M; Tsukada H; Magata Y; Ouchi Y
    Sci Rep; 2021 Jun; 11(1):13200. PubMed ID: 34168190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging mitochondrial complex I activation during a vibrotactile stimulation: A PET study using [
    Fang J; Ohba H; Hashimoto F; Tsukada H; Chen F; Liu H
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2521-2532. PubMed ID: 31948325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.
    Terada T; Therriault J; Kang MS; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Poltronetti NM; Ottoy J; Arias JF; Bezgin G; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Eur J Neurol; 2022 May; 29(5):1324-1334. PubMed ID: 35007366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain.
    Tsukada H; Ohba H; Nishiyama S; Kanazawa M; Kakiuchi T; Harada N
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):708-14. PubMed ID: 24447952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
    Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
    J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
    Harada N; Nishiyama S; Kanazawa M; Tsukada H
    J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.
    Tsukada H; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):755-63. PubMed ID: 24258008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma.
    Murayama C; Kawaguchi AT; Kamijo A; Naito K; Kanazawa M; Tsukada H
    PLoS One; 2017; 12(1):e0170911. PubMed ID: 28125711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.
    Terada T; Therriault J; Kang MSP; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Mol Neurodegener; 2021 Apr; 16(1):28. PubMed ID: 33902654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Adipose Tissue Browning using Mitochondrial Complex-I Tracer [
    Goggi JL; Hartimath S; Khanapur S; Ramasamy B; Tang JR; Cheng P; Barron AM; Tsukada H; Robins EG
    Contrast Media Mol Imaging; 2022; 2022():6113660. PubMed ID: 35694709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower Availability of Mitochondrial Complex I in Anterior Cingulate Cortex in Autism: A Positron Emission Tomography Study.
    Kato Y; Yokokura M; Iwabuchi T; Murayama C; Harada T; Goto T; Tamayama T; Kameno Y; Wakuda T; Kuwabara H; Benner S; Senju A; Tsukada H; Nishizawa S; Ouchi Y; Yamasue H
    Am J Psychiatry; 2023 Apr; 180(4):277-284. PubMed ID: 36069020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys.
    Tsukada H; Kanazawa M; Ohba H; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2016 Jun; 57(6):950-3. PubMed ID: 26912430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys.
    Tsukada H; Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2127-36. PubMed ID: 24919653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
    Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
    Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-retest variability and reference region-based quantification of
    Mansur A; Rabiner EA; Tsukada H; Comley RA; Lewis Y; Huiban M; Passchier J; Gunn RN
    J Cereb Blood Flow Metab; 2021 Apr; 41(4):771-779. PubMed ID: 32501157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Synthesis of
    Kaur T; Brooks AF; Liddell KM; Henderson BD; Hockley BG; Bohnen NI; Albin RL; Scott PJH
    Front Chem; 2022; 10():878835. PubMed ID: 35433631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain:
    Mansur A; Rabiner EA; Comley RA; Lewis Y; Middleton LT; Huiban M; Passchier J; Tsukada H; Gunn RN;
    J Nucl Med; 2020 Jan; 61(1):96-103. PubMed ID: 31324712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.
    Rissanen E; Carter K; Cicero S; Ficke J; Kijewski M; Park MA; Kijewski J; Stern E; Chitnis T; Silbersweig D; Weiner HL; Kim CK; Lyons J; Klein JP; Bhattacharyya S; Singhal T
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35091466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Ikegaya S; Kakiuchi T; Ohba H; Nishiyama S; Fukomoto D; Kanazawa M; Harada N; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2021 Dec; 18(1):288. PubMed ID: 34893067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.